Clin2
NCT07773012Possibly a fitNot yet recruiting

Probiotic treatment for newborn jaundice

Indirect Hyperbilirubinemia

Part of Genetic & congenital clinical trials.

This trial tests whether giving a probiotic (a beneficial bacteria) to newborns with jaundice helps lower bilirubin levels faster when combined with standard light therapy. If effective, this could shorten hospital stays and reduce the need for more invasive treatments.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
90 people
Ages
Up to 4 weeks
Study type
Interventional

Who can take part

  • Your baby must be 0 to 28 days old.
  • Your baby was born full-term (between 37 and 42 weeks of pregnancy).
  • Your baby has been diagnosed with jaundice that is not caused by a liver problem, and needs light therapy (phototherapy) as standard care.
  • You (or the legal guardian) must agree to let your baby take part in the study.
  • Your baby cannot join if they have serious health conditions like infections, major birth defects, or certain blood disorders.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07102836Recruiting· Phase 2
Zinc vs probiotics for jaundice in newborns on light therapy

This trial tests whether zinc or probiotics can help babies with jaundice recover faster while receiving phototherapy (light treatment). It aims to find a safe, easy way to lower bilirubin levels.

Bahawalpur, Punjab Province
NCT06702241Recruiting· Phase 2/Phase 3
Light therapy for newborn jaundice

This trial tests different ways to give light therapy to newborns with jaundice. It compares different approaches to see which is best, and may help parents understand the most effective treatment for their baby.

Aalborg
NCT07110987Recruiting
Adding a Medicine to Light Therapy for Newborn Jaundice

This study tests whether adding a medicine called Ursodeoxycholic Acid (UDCA) to standard light therapy (phototherapy) helps treat newborn jaundice more quickly. Jaundice causes yellow skin and eyes, and this trial looks at babies whose jaundice is severe enough to need light treatment.

Latakia
NCT04365998Recruiting
Testing a new light device for newborn jaundice

This study tests a new phototherapy (special light treatment) device to treat newborn jaundice. It may help by seeing whether this device can treat jaundice safely and effectively.

Lille
NCT07774741Not yet recruiting· Phase 4
Comparing two medicines plus light therapy for newborn jaundice

This study looks at whether adding a medicine (fenofibrate or phenobarbitone) to standard light therapy (phototherapy) can help lower bilirubin faster in newborns with jaundice. It compares the two medicines to see which one works better.

NCT06819150Recruiting
Bathing effects on babies getting light therapy for jaundice

This study looks at whether giving a bath to newborns receiving light therapy for jaundice helps with their comfort, skin health, and jaundice levels. If your baby is healthy except for jaundice and needs phototherapy, this study could show if bathing makes them feel better.

Kütahya, Merkez

Hear when a new Indirect Hyperbilirubinemia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.